Scienture Holdings, Inc. (NASDAQ:SCNX) Short Interest Update

Scienture Holdings, Inc. (NASDAQ:SCNX) was the recipient of a significant decrease in short interest in July. As of July 31st, there was short interest totaling 1,341,608 shares, a decrease of 48.4% from the July 15th total of 2,600,386 shares. Approximately 4.2% of the shares of the company are sold short. Based on an average daily volume of 317,449 shares, the short-interest ratio is currently 4.2 days.

Scienture Price Performance

Shares of SCNX stock traded up $0.00 during mid-day trading on Monday, reaching $0.46. The stock had a trading volume of 671,274 shares, compared to its average volume of 2,427,816. The company has a market cap of $18.78 million, a P/E ratio of -0.22 and a beta of 3.26. The company has a current ratio of 3.04, a quick ratio of 2.97 and a debt-to-equity ratio of 0.15. Scienture has a 12-month low of $0.24 and a 12-month high of $2.60. The business has a 50-day simple moving average of $0.38 and a 200 day simple moving average of $0.40.

Scienture (NASDAQ:SCNX) last released its quarterly earnings data on Thursday, August 13th. The company reported ($0.07) EPS for the quarter, topping the consensus estimate of ($0.09) by $0.02. The business had revenue of $0.34 million during the quarter, compared to analysts’ expectations of $1.96 million.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Scienture in a report on Wednesday, June 24th. One research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $1.50.

Institutional Trading of Scienture

A hedge fund recently raised its position in Scienture stock. Geode Capital Management LLC grew its holdings in Scienture Holdings, Inc. (NASDAQ:SCNX) by 264.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 316,201 shares of the company’s stock after purchasing an additional 229,398 shares during the quarter. Geode Capital Management LLC owned approximately 0.78% of Scienture worth $161,000 at the end of the most recent quarter. Institutional investors and hedge funds own 5.68% of the company’s stock.

Scienture Company Profile

Scienture Holdings, Inc engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.